Safety and Efficacy of γδ T Cell Against Gastric Cancer
Clinical trial NCT02585908 · UNKNOWN
Trial details
- NCT number
- NCT02585908
- Sponsor
- Beijing Doing Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2021-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.